{"id":100212,"date":"2012-12-19T15:45:26","date_gmt":"2012-12-19T15:45:26","guid":{"rendered":"https:\/\/knome.com\/?p=100212"},"modified":"2024-09-12T14:25:34","modified_gmt":"2024-09-12T14:25:34","slug":"2012-the-year-when-genomic-medicine-started-paying-off","status":"publish","type":"post","link":"https:\/\/www.knome.com\/?p=100212","title":{"rendered":"2012: The Year When Genomic Medicine Started Paying Off"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;section&#8221; _builder_version=&#8221;4.27.0&#8243; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_row admin_label=&#8221;row&#8221; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_heading title=&#8221;2012: The Year When Genomic Medicine Started Paying Off&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; title_text_color=&#8221;#E02B20&#8243; title_font_size=&#8221;25px&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221; sticky_enabled=&#8221;0&#8243;][\/et_pb_heading][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; text_font_size=&#8221;14px&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p><span><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg\" width=\"139\" height=\"140\" alt=\"\" class=\"wp-image-100213 alignnone size-full\" style=\"float: left;\" srcset=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg 249w, https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/xconomyFeature-2we28ic1viyddsjp5um41s-150x150.jpg 150w\" sizes=\"(max-width: 139px) 100vw, 139px\" \/>An excerpt of an interesting article mentioning Knome [emphasis ours]\u2026<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><em>Remember a couple of years ago when people commemorated the 10-year anniversary of the first draft human genome sequencing? The storyline then, in 200, was that we all went off to genome camp and only came home with a lousy T-shirt. Society, we were told, invested huge scientific resources in deciphering the code of life, and there wasn\u2019t much of a payoff in the form of customized, personalized medicine.<\/em><\/p>\n<p><em>That was an easy conclusion to reach then, when personalized medicine advocates could only point to a couple of effective targeted cancer drugs\u2014Genentech\u2019s Herceptin and Novartis\u2019 Gleevec\u2014and a couple of diagnostics. But that\u2019s changing. My inbox the past week has been full of analyst reports from medical meetings, which mostly alerted readers to mere \u201cincremental\u201d advances with a number of genomic-based medicines and diagnostics. But that\u2019s a matter of focusing on the trees, not the forest. This past year, we witnessed some really impressive progress from the early days of \u201cclinical genomics\u201d or \u201cmedical genomics.\u201d The investment in deep understanding of genomics and biology is starting to look visionary.<\/em><\/p>\n<p><em>The movement toward clinical genomics gathered steam back in June at the American Society of Clinical Oncology annual meeting.<span>\u00a0<\/span><strong>One of the hidden gem stories from ASCO was about little companies like Cambridge, MA-based Foundation Medicine and Cambridge, MA-based Knome that started seeing a surprising surge in demand from physicians for their services to help turn genomic data into medical information.<\/strong><span>\u00a0<\/span>The New York Times wrote a great story a month later about a young genomics researcher at Washington University in St. Louis who got cancer, had access to incredibly rich information about his tumors, and\u2014after some wrestling with his insurance company\u2014ended up getting a targeted drug nobody would have thought to prescribe without that information. And last month, I checked back on Stanford University researcher Mike Snyder, who made headlines this year using a smorgasbord of \u201comics\u201d tools to correctly diagnose himself early with Type 2 diabetes, and then monitor his progress back into a healthy state.<\/em><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>An excerpt of an interesting article mentioning Knome [emphasis ours]\u2026 &nbsp; Remember a couple of years ago when people commemorated the 10-year anniversary of the first draft human genome sequencing? The storyline then, in 200, was that we all went off to genome camp and only came home with a lousy T-shirt. Society, we were [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":100213,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<img class=\"size-full wp-image-100015 alignleft\" src=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/GENALICE.jpg\" alt=\"\" width=\"300\" height=\"70\" \/>\r\n\r\nHARDERWIJK, the Netherlands and CAMBRIDGE, Mass \u2013 January 12, 2015 \u2013 Today GENALICE and Knome, Inc. USA jointly announced a strategic partnership to offer their products together as a turn-key solution for those using next-generation sequencing (NGS) data to interpret patients\u2019 genomes. GENALICE MAP is an ultra-fast and highly accurate preprocessing solution for aligning and calling NGS data and seamlessly connects to Knome\u2019s informatics and genomics interpretation system, the knoSYS<sup>\u00ae<\/sup>\u00a0platform.\r\n\r\nStated CEO and President of Knome, Wolfgang Daum, \u201cThe GENALICE and Knome partnership came about in response to the reality that the amount of NGS data and its increasing usage requires processing and interpreting at an incredible pace. Wide-spread implementation of sequencing in the clinic toward the goal of precision medicine will only make this fact more apparent.\u201d\r\n\r\nWhile both products will continue to be offered separately, customers wanting to take advantage of the combined system can expect a reduction of NGS data bottlenecks, improved ability to annotate and interpret human genomes, and unprecedented control over their data from end-to-end.\r\n\r\nHans Karten, CEO of GENALICE, commented, \u201cWhereas GENALICE MAP speeds up and improves the process of aligning and calling genomes, the knoSYS platform focuses on the annotation and interpretation piece. These two products complement each other beautifully in creating a workflow that eliminates many of the frustrations of wrangling NGS data today.\u201d\r\n\r\n<strong>About Knome, Inc.<\/strong>\r\nKnome, Inc. is a leading provider of human genome interpretation systems and services. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response. Designed to accelerate and industrialize the process of interpreting whole genomes, Knome\u2019s big data technologies are helping to smooth the healthcare industry\u2019s transition to molecular-based, precision medicine.\r\n\r\n<strong>About GENALICE<\/strong>\r\nGENALICE is a highly innovative biomedical big data company, with global headquarters in the Netherlands. GENALICE designs and builds groundbreaking software solutions for ultra-fast, highly accurate and cost-effective DNA data processing and analysis on general-purpose hardware. With GENALICE MAP, it introduced the first Next-Generation Sequencing (NGS) data processing pipeline with true population power. By partnering with world-renowned research institutes and healthcare companies, GENALICE is committed to unlocking the potential of whole genome and exome sequencing for biomarker discovery and medical application. More information on GENALICE can be found at\u00a0<a href=\"http:\/\/www.genalice.com\/\" target=\"_blank\" rel=\"noopener\">www.genalice.com<\/a>.\r\n\r\n<strong>Media Contacts<\/strong>\r\n<div>Knome, Inc. USA\r\nJessica Vionas\r\nDirector of Marketing\r\n617-715-1000 x2012\r\njvionas@knome.com<\/div>\r\n<div>GENALICE B.V.\r\nJos Lunenberg\r\nChief Business Officer\r\n+31 88 1221 000\r\njos.lunenberg@genalice.com<\/div>\r\n<p align=\"center\">###<\/p>\r\n<p align=\"center\"><\/p>","_et_gb_content_width":"","footnotes":""},"categories":[15],"tags":[],"class_list":["post-100212","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-in-the-media"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>2012: The Year When Genomic Medicine Started Paying Off<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.knome.com\/?p=100212\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2012: The Year When Genomic Medicine Started Paying Off\" \/>\n<meta property=\"og:description\" content=\"An excerpt of an interesting article mentioning Knome [emphasis ours]\u2026 &nbsp; Remember a couple of years ago when people commemorated the 10-year anniversary of the first draft human genome sequencing? The storyline then, in 200, was that we all went off to genome camp and only came home with a lousy T-shirt. Society, we were [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.knome.com\/?p=100212\" \/>\n<meta property=\"og:site_name\" content=\"Knome | Genome Interpretation Systems &amp; Services\" \/>\n<meta property=\"article:published_time\" content=\"2012-12-19T15:45:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-12T14:25:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"249\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jason Bailey\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jason Bailey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100212#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100212\"},\"author\":{\"name\":\"Jason Bailey\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\"},\"headline\":\"2012: The Year When Genomic Medicine Started Paying Off\",\"datePublished\":\"2012-12-19T15:45:26+00:00\",\"dateModified\":\"2024-09-12T14:25:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100212\"},\"wordCount\":535,\"image\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100212#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg\",\"articleSection\":[\"In The Media\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100212\",\"url\":\"https:\\\/\\\/www.knome.com\\\/?p=100212\",\"name\":\"2012: The Year When Genomic Medicine Started Paying Off\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100212#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100212#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg\",\"datePublished\":\"2012-12-19T15:45:26+00:00\",\"dateModified\":\"2024-09-12T14:25:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100212#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.knome.com\\\/?p=100212\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100212#primaryimage\",\"url\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg\",\"contentUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg\",\"width\":249,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100212#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.knome.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2012: The Year When Genomic Medicine Started Paying Off\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#website\",\"url\":\"https:\\\/\\\/www.knome.com\\\/\",\"name\":\"Knome | Genome Interpretation Systems &amp; Services\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.knome.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\",\"name\":\"Jason Bailey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"caption\":\"Jason Bailey\"},\"url\":\"https:\\\/\\\/www.knome.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2012: The Year When Genomic Medicine Started Paying Off","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.knome.com\/?p=100212","og_locale":"en_US","og_type":"article","og_title":"2012: The Year When Genomic Medicine Started Paying Off","og_description":"An excerpt of an interesting article mentioning Knome [emphasis ours]\u2026 &nbsp; Remember a couple of years ago when people commemorated the 10-year anniversary of the first draft human genome sequencing? The storyline then, in 200, was that we all went off to genome camp and only came home with a lousy T-shirt. Society, we were [&hellip;]","og_url":"https:\/\/www.knome.com\/?p=100212","og_site_name":"Knome | Genome Interpretation Systems &amp; Services","article_published_time":"2012-12-19T15:45:26+00:00","article_modified_time":"2024-09-12T14:25:34+00:00","og_image":[{"width":249,"height":250,"url":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg","type":"image\/jpeg"}],"author":"Jason Bailey","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jason Bailey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.knome.com\/?p=100212#article","isPartOf":{"@id":"https:\/\/www.knome.com\/?p=100212"},"author":{"name":"Jason Bailey","@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3"},"headline":"2012: The Year When Genomic Medicine Started Paying Off","datePublished":"2012-12-19T15:45:26+00:00","dateModified":"2024-09-12T14:25:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.knome.com\/?p=100212"},"wordCount":535,"image":{"@id":"https:\/\/www.knome.com\/?p=100212#primaryimage"},"thumbnailUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg","articleSection":["In The Media"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.knome.com\/?p=100212","url":"https:\/\/www.knome.com\/?p=100212","name":"2012: The Year When Genomic Medicine Started Paying Off","isPartOf":{"@id":"https:\/\/www.knome.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.knome.com\/?p=100212#primaryimage"},"image":{"@id":"https:\/\/www.knome.com\/?p=100212#primaryimage"},"thumbnailUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg","datePublished":"2012-12-19T15:45:26+00:00","dateModified":"2024-09-12T14:25:34+00:00","author":{"@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3"},"breadcrumb":{"@id":"https:\/\/www.knome.com\/?p=100212#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.knome.com\/?p=100212"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.knome.com\/?p=100212#primaryimage","url":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg","contentUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/xconomyFeature-2we28ic1viyddsjp5um41s.jpg","width":249,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/www.knome.com\/?p=100212#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.knome.com\/"},{"@type":"ListItem","position":2,"name":"2012: The Year When Genomic Medicine Started Paying Off"}]},{"@type":"WebSite","@id":"https:\/\/www.knome.com\/#website","url":"https:\/\/www.knome.com\/","name":"Knome | Genome Interpretation Systems &amp; Services","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.knome.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3","name":"Jason Bailey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","url":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","caption":"Jason Bailey"},"url":"https:\/\/www.knome.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=100212"}],"version-history":[{"count":3,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100212\/revisions"}],"predecessor-version":[{"id":100216,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100212\/revisions\/100216"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/media\/100213"}],"wp:attachment":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=100212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=100212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=100212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}